Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 [Revised]Organization of Investor Relations Event 2020/08/18 HANALL BIOPHARMA CO.,LTD
9 Organization of Investor Relations Event 2020/08/14 HANALL BIOPHARMA CO.,LTD
8 Decision on Disposal Treasury Stocks 2020/07/29 HANALL BIOPHARMA CO.,LTD
7 Interim Report on Business Performance(Fair Disclosure) 2020/07/29 HANALL BIOPHARMA CO.,LTD
6 Other Management Information(Voluntary Disclosure) 2020/05/25 HANALL BIOPHARMA CO.,LTD
5 Interim Report on Business Performance(Fair Disclosure) 2020/05/08 HANALL BIOPHARMA CO.,LTD
4 Suspension of Trading and Resumption of Trading Thereafter(As a result of Disclosure of Important Corporate Information) 2020/05/08 HANALL BIOPHARMA CO.,LTD
3 Suspension of Business Operation 2020/05/08 HANALL BIOPHARMA CO.,LTD
2 [Investment Caution] Issue traded by linked accounts with high market influence 2020/03/30 HANALL BIOPHARMA CO.,LTD
1 Outcome of Annual Shareholders' Meeting 2020/03/20 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
3 2019 Statement of financial position 2020-03-20
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31